Skip to content
zameds

Imipenem And Cilastatin Adco

Cilastatin, imipenem

Loading the molecular structure
C16H26N2O5S358.50 g/mol

(Z)-7-[(2R)-2-Amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 6435415.

Registration

Applicants
1
Registrations
1

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Adcock Ingram Critical Care (Pty) LtdImipenem and cilastatin adco500 mg/20 ml440796Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Imipenem and cilastatin adco 500 mg/20 ML

EACH VIAL CONTAINS: IMIPENEM MONOHYDRATE EQUIVALENT TO ANHYDROUS IMIPENEM 500,0 mg CILASTATIN SODIUM EQUIVALENT TO CILASTATIN 500,0 mg

500 mg/20 ml44079644/20.1.1/0796RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Cilastatin

    Consolidated Schedules 06 July 2026, line 5807

  • S4: Imipenem

    Consolidated Schedules 06 July 2026, line 6738

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsImipenem and cilastatin adco 500 mg/20 ML, Adcock Ingram Critical Care (Pty) Ltd. SAHPRA's document for IMIPENEM AND CILASTATIN ADCOPatient information leaflet (PIL)For patients and carersImipenem and cilastatin adco 500 mg/20 ML, Adcock Ingram Critical Care (Pty) Ltd. SAHPRA's document for IMIPENEM AND CILASTATIN ADCO

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles